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Pseudomonas aeruginosa hemolytic phospholipase C, PlcH, can degrade phosphatidylcholine (PC) and
sphingomyelin in eukaryotic cell membranes and extracellular PC in lung surfactant. Numerous studies
implicate PlcH in P. aeruginosa virulence. The phosphorylcholine released by PlcH activity on phospholipids
is hydrolyzed by a periplasmic phosphorylcholine phosphatase, PchP. Both plcH gene expression and PchP
enzyme activity are positively regulated by phosphorylcholine degradation products, including glycine betaine.
Here we report that the induction of plcH and pchP transcription by glycine betaine is mediated by GbdR, an
AraC family transcription factor. Mutants that lack gbdR are unable to induce plcH and pchP in media
containing glycine betaine or choline and in phosphatidylcholine-rich environments, such as lung surfactant
or mouse lung lavage fluid. In T broth containing choline, the gbdR mutant exhibited a 95% reduction in PlcH
activity. In electrophoretic mobility shift assays, a GbdR-maltose binding protein fusion bound specifically to
both the plcH and pchP promoters. Promoter mapping, alignment of GbdR-regulated promoter sequences, and
analysis of targeted promoter mutants that lack GbdR-dependent induction of transcription were used to
identify a region necessary for GbdR-dependent transcriptional activation. GbdR also plays a significant role
in plcH and pchP regulation within the mouse lung. Our studies suggest that GbdR is the primary regulator
of plcH and pchP expression in PC-rich environments, such as the lung, and that pchP and other genes involved
in phosphorylcholine catabolism are necessary to stimulate the GbdR-mediated positive feedback induction of
plcH.
The Pseudomonas aeruginosa plcH gene encodes a hemolytic
phospholipase C (PLC) with high specificity for phosphatidyl-
choline (PC) and sphingomyelin (SM) (4). Studies have shown
PlcH to have both pathogenic activities and proinflammatory
capability (3, 21, 45). In addition, PlcH is important for P.
aeruginosa virulence in mice (29), rabbits (46), insects (12),
plants (28, 29), and Candida albicans (10). Purified PlcH is
capable of inducing pulmonary inflammation and inhibits the
oxidative burst of neutrophils (40, 45). Evidence also suggests
that P. aeruginosa PlcH-mediated degradation of the PC in
lung surfactant contributes to lung infections (16).
The enzymatic activity of PlcH on either PC or SM releases
phosphorylcholine (ChoP), which can be dephosphorylated in
the periplasm by a phosphatase, PchP, to yield choline (20).
Choline is actively transported into the cytoplasm (19, 33),
where it can be used in a variety of different ways. P. aeruginosa
BetAB catalyzes the conversion of choline to glycine betaine
(GB), which is both a potent osmoprotectant (9) and a source
of carbon, nitrogen, and energy (13). During catabolism of GB,
it is successively demethylated to form dimethylglycine
(DMG), sarcosine (monomethylglycine), and finally glycine (7,
43). Microarray studies of cystic fibrosis (CF) patient sputum
samples showed that in the lungs of CF patients, P. aeruginosa
induces plcH and genes involved in both choline and diacyl-
glycerol catabolism, which supports the hypothesis that PlcH is
important for P. aeruginosa colonization of the lung (39).
PlcH activity provides the P. aeruginosa cell with ChoP, a
source of both phosphate and choline, and both of these prod-
ucts participate in the regulation of plcH transcription (36).
Shortridge et al. (36) have shown that plcH transcription is
induced by phosphate limitation in a PhoB-dependent manner.
The plcH gene is also transcriptionally induced in response to
choline and its downstream catabolic products, GB and DMG
(32, 36). Induction of plcH by GB and DMG is PhoB indepen-
dent, and there is evidence for distinct transcriptional start
sites for phosphate limitation-induced and choline-induced
transcripts (32, 36, 41). The inability of choline to induce plcH
in a mutant defective for betB, required for conversion of
choline to GB, provided evidence that choline is not a direct
activator of plcH transcription, but rather that GB and DMG
are the inducers (31). The transcription factor responsible for
this induction has not previously been described.
Here we show that GbdR, an AraC family transcription
factor that is required for the induction of the GB and DMG
catabolic genes in response to GB and DMG (43), also regu-
lates the expression of plcH and pchP in a similar manner.
Through deletion mapping, electrophoretic mobility shift as-
says, and targeted promoter mutagenesis, we have identified
residues that are required for GB- and DMG-dependent in-
duction of plcH and pchP. We show that GbdR is critical for
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induction of plcH and pchP in response to bovine surfactant
and mouse bronchoalveolar lavage fluid (BALF). Analysis of
P. aeruginosa transcripts during acute murine lung infection
also indicated that GbdR is important for the induction of plcH
and pchP in vivo.
MATERIALS AND METHODS
Strains, media, and growth conditions. P. aeruginosa PAO1 and PA14 wild-
type (WT) strains and deletion strains, as well as Escherichia coli strains (Table
1), were maintained on Luria broth (LB) medium. For transcriptional induction
studies, cells were grown overnight in morpholinepropanesulfonic acid (MOPS)
minimal medium (24) amended with 25 mM sodium pyruvate and 5 mM D-
glucose prior to transfer to inducing medium. When necessary, gentamicin was
added to a final concentration of 10 g/ml for E. coli, 50 g/ml for P. aeruginosa
in LB medium, and 25 g/ml for P. aeruginosa in MOPS medium.
PLC activity assays. PLC activity was measured using the artificial substrate
-nitrophenyl-phosphorylcholine (NPPC) by the method described by Kurioka
and Matsuda (15). Bacteria were grown overnight in 5 ml of tryptone broth or
tryptone broth plus 5 mM choline overnight at 37°C. The reaction buffer was 100
mM Tris-HCl (pH 7.2), 25% glycerol, and 20 mM NPPC. NPPC hydrolysis was
detected by measuring the absorbance at 410 nm. Hemolytic activity was ana-
lyzed on agar plates containing 5% defibrinated sheep blood. To eliminate plcH
induction in response to phosphate limitation, 500 l of 1 M potassium phos-
phate (pH 7.0) solution was top spread and the plates were allowed to dry prior
to inoculation with P. aeruginosa strains. After 24 h of incubation at 37°C,
hemolytic activity was detected by clear halos, which were photographed after
removal of the bacteria from the plate by scraping with a coverslip.
RNA isolation, RT, and qRT-PCR. For in vitro gene induction experiments
using reverse transcription-PCR (RT-PCR), cells were grown overnight in
MOPS with 20 mM pyruvate and 5 mM glucose. Cells were harvested by cen-
trifugation, resuspended in MOPS with 20 mM pyruvate and 10 mM of the
inducing carbon source, and grown for 2 h at 37°C. RNAs were isolated from
107 cells by use of an RNeasy kit (Qiagen). Pyruvate served as a growth
substrate to allow growth without detectable catabolite repression of GB-in-
duced genes (7; data not shown). During isolation, RNAs were treated with an
on-column DNase I treatment (Qiagen) for 30 min at room temperature. The
resulting RNAs were subjected to PCR to verify the absence of contaminating
DNA before being quantified using a Nanodrop spectrophotometer. cDNA was
synthesized using Superscript III (Invitrogen) from 300 ng of starting RNA, with
a 5-NSNSNSNSNS-3 primer instead of random hexamers. The regimen for
cDNA synthesis was 25°C for 5 min, 52°C for 60 min, and 70°C for 15 min.
Primers used are listed in Table S1 in the supplemental material. The PCR
regimen was 94°C for 5 min, followed by 30 cycles of 94°C for 30 s, 56°C for 30 s,
and 72°C for 30 s. Quantitative real-time RT-PCR (qRT-PCR) was conducted
with Power SYBR green with AmpliTaq Gold DNA polymerase according to the
manufacturer’s instructions (Applied Biosystems).
Analysis of plcH promoter activities by use of lacZYA fusions. The pMW5
reporter construct was generated by amplifying the lacZYA operon from plasmid
pRS415 (37), using specific primers with KpnI and EcoRI sites, and digesting the
product with KpnI and EcoRI, followed by ligation into similarly digested
pUCP22 (34). This placed the lacZYA operon in an orientation opposite that of
the pUCP22 lacZ alpha fragment and the corresponding promoter, leaving the
majority of the polycloning region intact. This construct shows very little back-
ground -galactosidase activity in P. aeruginosa.
We constructed a deletion series of the plcH promoter by using PCR to
amplify products from the pAES110 plcH::lacZYA fusion construct (32). Primers
used for these constructs are detailed in Table S1 in the supplemental material.
Briefly, each PCR product was gel purified, digested with XbaI and BamHI, and
ligated into similarly digested pMW5. Ligation mixtures were transformed into
E. coli DH5 cells (Invitrogen) by chemical transformation. Plasmid prepara-
tions from E. coli clones were transformed into P. aeruginosa by electroporation
(5) and selected for growth on gentamicin. After overnight growth in MOPS-
pyruvate-glucose medium as described above, cells were pelleted and resus-
pended in MOPS with 25 mM pyruvate and 2 mM of the inducing compound and
grown under inducing conditions for 4 h at 37°C unless otherwise specified. The
-galactosidase assays were conducted according to the method of Miller (23).
Analysis of plcH reporter expression in Survanta (Abbott) was done using the
specified P. aeruginosa strains carrying the pMW22 reporter plasmid. Survanta
was diluted in MOPS with no additional carbon source (1:100). Additions of
phosphorylcholine, choline, or GB (all from Sigma) were such that the final
concentration of each additive was 0.25 mM. This concentration approximates
that which would be derived if all PC in Survanta were hydrolyzed and every
subsequent enzymatic step proceeded to completion.
Analysis of the pchP promoter by use of promoter fusions to gfp. The pchP
promoter deletion series was constructed by amplifying fragments from PAO1
genomic DNA. Primers for these constructs are detailed in Table S1 in the
supplemental material. pMW47 was generated by amplification of the gfp-mut3
gene from pMQ80 (35) with adaptor primers. This product was digested with
HindIII and EcoRI and ligated to a similarly cut pMQ80 backbone. This left the
gfp gene in reverse orientation to the arabinose-inducible promoter region of
pMQ80 and allowed yeast-based cloning of promoters in front of gfp. Briefly,
each PCR product was gel purified and transformed along with KpnI-linearized
pMW47 into Saccharomyces cerevisiae according to the method of Shanks et al.
(35). Yeast cells were plated onto synthetic complete plates lacking uracil, and
colonies were picked after 48 h at 30°C. Plasmid DNA was isolated from yeast
according to the method of Shanks et al. (35). Transformation of the plasmids
TABLE 1. Strain and plasmid list
Strain or plasmid Strain no. Description
Strains
P. aeruginosa
strains
PAO1 DH20 P. aeruginosa WT
gbdR DH543 In-frame PA5380 deletion in
PAO1 (43)
gbdR att::gbdR DH1008 Complementation of the gbdR
deletion at the att site
gbcAB DH841 In-frame PA5410 and PA5411
deletions in PAO1 (43)
dgcA DH1178 In-frame PA5398 deletion in
PAO1 (43)
plcHR DH860 In-frame plcHR deletion in PAO1
(36)
pchP::Tn5 DH503 PAO1 transposon mutant 10802
betB::Tn5 DH491 PAO1 transposon mutant 104
PA14 DH122 P. aeruginosa WT (31)
gbdR DH466 In-frame PA5380 deletion in PA14
(43)
E. coli strains
S17/pir DH522
Ec-PA5380KO DH540 DH522 with pPA5380KO; Gmr
Plasmids
pUCP22 High-copy-number Pseudomonas
stabilized vector; Gmr (34)
pMQ30 Suicide vector; Gmr (35)
pMQ80 High-copy-number Pseudomonas-
yeast shuttle vector (35)
pMW5 pUCP22 containing lacZYA from
pRS415
pMW22 plcH promoter fragment (positions
	374 to 	13) in pMW5
pMW23 plcH promoter fragment (positions
	248 to 	13) in pMW5
pMW24 plcH promoter fragment (positions
	177 to 	13) in pMW5
pMW25 plcH promoter fragment (positions
	86 to 	13) in pMW5
pMW26 MBP-GbdR expression vector
(pMalc derivative)
pMW47 GFP reporter vector based on
modified pMQ80
pMW71 pchP promoter fragment (positions
	369 to 	15) in pMW47
pMW72 pchP promoter fragment (positions
	275 to 	15) in pMW47
pMW73 pchP promoter fragment (positions
	141 to 	15) in pMW47
pMW84 pchP promoter fragment (positions
	75 to 	15) in pMW47
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into E. coli and mobilization into P. aeruginosa were done as described for the
plcH promoter fusion constructs. Cells were induced as described for the plcH
promoter studies. Fluorescence was measured in black-walled 96-well dishes,
using a Bio-Tek Instruments model Fix-800I fluorometer with an excitation
wavelength of 485 nm and a 528-nm emission filter. Background autofluores-
cence of PAO1 was subtracted by measuring the fluorescence of identically
grown cells carrying a Gmr plasmid but no gfp gene.
EMSA. We constructed a maltose binding protein (MBP) fusion to GbdR
(pMW26) by using the pMALc vector system (NEB). E. coli DH5 carrying the
pMW26 plasmid was grown overnight in LB plus 120 g/ml carbenicillin. The
overnight culture was transferred to four 250-ml flasks containing 50 ml of
LB-carbenicillin and shaken at 220 rpm for 4 h. IPTG (isopropyl--D-thiogalacto-
pyranoside) was added to 0.2 mM, and the cells were induced for 5 h. Cells were
pelleted, lysed in column buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM
EDTA) with 3 mg/ml lysozyme, clarified by centrifugation, and filtered through
a 0.22-m membrane before being applied to an amylose column. The column
was washed with eight column volumes of column buffer, and protein was eluted
in column buffer with 10 mM maltose. The fractions containing the fusion
protein were dialyzed against 20 mM Tris-HCl, pH 7.5, 125 mM KCl, 1 mM
MgCl2, 5% glycerol at 4°C in a dialysis cassette (10,000-molecular-weight cutoff;
Pierce). The full-length fusion protein was used in electrophoretic mobility shift
assays (EMSAs), as the Xa cleavage product was insoluble (data not shown). We
verified the ability of MBP-GbdR to function in vivo by the restoration of growth
on GB to the gbdR mutant by a plasmid expressing the pMAL-GbdR fusion
(data not shown).
DNA fragments for EMSA analysis were created by PCR amplification, ver-
ification of the presence of a single band, and spot dialysis of the product. DNA
was diluted to the specified concentration from this preparation. For labeled
DNA, one of the primers contained a covalently linked 5-biotin tag (IDT).
EMSA experiments were conducted per the manufacturer’s instructions (Pierce
LightShift), with the following changes. First, buffer conditions were optimized to
be similar to those used for other Pseudomonas AraC family proteins (22). This
resulted in a final binding reaction buffer containing 1
 Pierce binding buffer (10
mM Tris-HCl, pH 7.5, 50 mM KCl, 1 mM dithiothreitol), 0.1 mM GB, 0.2 g/l
poly(dI-dC), 3 mM MgCl2, 7% glycerol, 1 mM EDTA, and 50 g/ml bovine
serum albumin. To reduce the formation of insoluble precipitates with the pchP
probe, bovine serum albumin was increased to 250 g/ml. Where included,
unlabeled competitor DNA was present at 0.6 pmol/l, labeled probe DNA was
present at 1 fmol/l, and MBP-GbdR was added to a final concentration of 0 to
3.0 M. Binding reactions were carried out at 37°C for 40 min. Binding reactions
were run in nondenaturing 5% Tris-borate-EDTA gels (Bio-Rad), transferred to
BioDyne nylon membranes (Pierce), and detected using the supplied streptavi-
din-horseradish peroxidase protocol (Pierce).
In vitro P. aeruginosa gene induction in response to bovine surfactant and
murine BALF. For in vitro surfactant and BALF experiments, P. aeruginosa was
pregrown in MOPS medium as described for qRT-PCR. For the surfactant study,
cells from overnight cultures were pelleted and resuspended in either MOPS plus
10 mM pyruvate or a 1:50 dilution of Survanta in MOPS plus 10 mM pyruvate,
resulting in a phospholipid concentration of 0.5 mg/ml total phospholipid. BALF
for in vitro P. aeruginosa gene induction studies was harvested from uninfected
adult male C57BL/6 mice. Mice were anesthetized with intraperitoneal sodium
pentobarbital (70 to 90 mg/kg of body weight). Tracheas were cannulated with 2
cm of 22-gauge polyethylene tubing attached to a 23-gauge needle, 1 ml of cold
Dulbecco’s phosphate-buffered saline (DPBS) was instilled into the lungs, and
the BALF was collected. The BALF was sterile filtered and frozen at	80°C until
use. For the BALF experiment, cells were resuspended in DPBS plus 10 mM
pyruvate or into BALF plus 10 mM pyruvate. For both analyses, cells were
shaken at 37°C for 2 h and RNAs were prepared as described above.
Mouse lung infection. Male C57BL/6 mice (Jackson Labs) of 8 to 12 weeks of
age were inoculated with 1 
 108 CFU of P. aeruginosa PAO1 via oropharyngeal
aspiration following brief anesthesia with isoflurane (1). The infection proceeded
for 24 hours, followed by nonsurvival surgery and acquisition of BALF by the
same methods described above for uninfected animals. Samples were immedi-
ately treated with RNAprotect bacterial reagent (Qiagen) per the manufacturer’s
instructions. RNA isolation was performed as described above, with the follow-
ing change: 95 to 160 ng total RNA was used to generate cDNA. The amplifi-
cation conditions were 95°C for 10 min followed by 40 cycles of 95°C for 15 s,
56°C for 1 min, and 72°C for 1 min, using an Applied Biosystems 7500 Fast
instrument. Only one PCR product was obtained for all primers and all samples,
based on melting curve analysis. All procedures that involved mice were ap-
proved by the University of Vermont Institutional Animal Care and Use Com-
mittee.
RESULTS
plcH and pchP induction in response to choline, GB, and
DMG is dependent on the GbdR transcription factor. In pre-
viously published studies, we showed that the GbdR transcrip-
tion factor controls the expression of gbcAB and dgcAB, which
are required for GB and DMG degradation, respectively, in
response to both GB and DMG (43). Because plcH expression,
PlcH activity, and PchP activity are similarly induced by these
two osmoprotectants (18, 36), we hypothesized that GbdR may
be the GB- and DMG-dependent regulator of plcH and pchP
induction. To test this hypothesis, PlcH activity was first as-
sessed in gbdR mutant cultures by both the NPPC hydrolysis
assay and assessing hemolysis on blood agar plates. Cultures of
P. aeruginosa PAO1 WT, PAO1 gbdR, PAO1 plcHR, and
PAO1 gbdR complemented with a functional copy of gbdR at
the att site were grown in T broth with choline, and the super-
natants were analyzed for NPPC hydrolysis activity (Fig. 1A).
In WT supernatants, the addition of choline to the medium led
to a 4.2-fold increase in NPPC hydrolysis activity; no increase
in NPPC cleavage activity was observed upon addition of cho-
line in either the gbdR or plcHR strain. Complementation of
the gbdR mutant partially restored the induction of PlcH ac-
tivity in response to choline (Fig. 1A). In the blood agar
hemolysis assay, zones of clearing were observed around the WT
but not the plcH and gbdR mutants. Complementation of
the gbdR mutant restored hemolytic activity (Fig. 1B).
The regulation of PlcH enzyme activity by GbdR suggested
the possibility that GbdR regulates the induction of plcH tran-
scription. plcH transcription has been shown to be induced in
response to choline, GB, and DMG (36), and induction by
choline is not observed in a betB mutant strain which cannot
convert choline to GB, indicating that GB and/or its catabolic
product DMG is the compound responsible for plcH induction
in choline-containing media (31). We have shown that either
GB or DMG can stimulate GbdR-dependent transcription of
the GB catabolic genes even in a mutant (gbcAB) that is
unable to convert GB to DMG, suggesting that both GB and
DMG can serve as inducing compounds (43). To determine if
GbdR also regulates plcH induction by GB and DMG, we used
qRT-PCR to measure plcH transcripts in WT and gbdR
strains (Fig. 1C). plcH mRNA levels were assessed in both
MOPS minimal medium with pyruvate, in which plcH tran-
script levels are very low, and in the same medium amended
with GB. The plcH transcript levels are reported as relative
changes between uninduced (pyruvate) and induced (GB) con-
ditions. The relative transcript level for each strain was nor-
malized to the rplU transcript, which has been shown to remain
constant relative to total RNA under a variety of conditions
(14). In the presence of GB, the plcH transcript was induced
2.4-  0.09-fold in the WT (Fig. 1C), while no induction was
observed in the gbdR strain (0.88-  0.06-fold change). In-
corporation of gbdR at the att chromosomal site almost fully
complemented the phenotype of the gbdR strain (2.09- 
0.08-fold induction). Induction with DMG showed a similar
pattern of plcH transcriptional activation, in a gbdR-dependent
manner (data not shown). Similar results were obtained with P.
aeruginosa strain PA14, with a 6.69-  0.44-fold induction of
plcH transcript upon induction with GB and no induction
(0.64-  0.03-fold) in the gbdR mutant (Fig. 1D). These data
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support the hypothesis that plcH transcription is regulated by
GbdR.
Phosphorylcholine, a product of PlcH-mediated cleavage of
PC and SM, is hydrolyzed by the periplasmic phosphorylcho-
line phosphatase, PchP, to yield choline. While to our knowl-
edge induction conditions for the pchP transcript have not
previously been reported in the literature, functional assays
have been used to demonstrate induction of enzyme activity in
response to choline, GB, and DMG, similar to the regulation
observed for plcH (18, 20). We hypothesized that pchP induc-
tion was also dependent on GbdR. Similar to the results with
plcH, the pchP transcript was induced in response to GB com-
pared to pyruvate in PAO1 WT (4.5-  0.7-fold) (Fig. 1B) but
not in the gbdR strain (0.71-  0.1-fold). Integration of gbdR
at the att chromosomal site partially rescued the GB-depen-
dent induction (3.1-  0.3-fold). A similar pattern of induction
of pchP by GB in a GbdR-dependent manner was observed in
P. aeruginosa strain PA14 (Fig. 1D). These data support the
regulation of pchP by GbdR in a manner similar to that of
plcH.
Our previous studies with GbdR demonstrated that either
GB or DMG could induce GbdR-dependent transcription of
GB and DMG catabolic genes, and therefore we hypothesized
that both GB and DMG would be capable of inducing plcH
and pchP. To test this, we analyzed plcH and pchP transcript
levels in strains unable to catabolize either compound (43). In
a P. aeruginosa PAO1 gbcAB strain, which is unable to con-
vert GB to DMG, both GB and DMG induced the plcH tran-
script (3.62-  0.87-fold and 3.23-  0.64-fold, respectively). In
a P. aeruginosa PAO1 dgcA mutant, which is unable to con-
vert DMG to sarcosine, DMG was sufficient to induce plcH
transcription 2.88-  0.35-fold. Together, these data indicate
that both GB and DMG are capable of stimulating plcH tran-
scription.
Deletion mapping to determine the region necessary for
GbdR-dependent induction in the plcH and pchP promoters.
To determine the segment of each promoter that was neces-
sary for GbdR-dependent activation of plcH and pchP tran-
scription, plcH and pchP promoter fragments were cloned up-
stream of the lacZYA and gfp-mut3 reporter genes, respectively
(Fig. 2A and B). The resulting constructs were transformed
into both WT and gbdR backgrounds. Transcriptional activa-
tion was assessed in cells grown either in medium with pyru-
vate as the sole source of carbon or in medium containing
pyruvate plus GB. For the full-length plcH fragment (plcH-A)
and two of the truncated fragments (plcH-B and plcH-C),
transcriptional activation was observed in the WT strain but
not in the gbdR mutant (Fig. 2A). The smallest promoter
FIG. 1. Role of GbdR transcription factor in controlling PlcH activity and plcH transcript levels. (A and B) PAO1 WT, plcHR and gbdR
mutants, and a gbdR mutant complemented with gbdR at the att locus (gbdR att::gbdR) were assayed for choline-induced NPPC hydrolysis
activity in cultures grown in T broth (TB) (black bars) or T broth containing choline (white bars) (A) and in a hemolysis assay using
phosphate-supplemented blood agar plates (B). (C and D) qRT-PCR quantification of plcH and pchP transcript levels normalized to rplU levels
in P. aeruginosa strains PAO1 (C) and PA14 (D). Transcript induction is reported as the transcript level measured under inducing conditions (GB)
divided by the transcript level under noninducing conditions (pyruvate). Error bars represent standard deviations between levels in three replicate
cultures, and results were comparable between at least three separate experiments.
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fragment (plcH-D) failed to show GB-dependent induction
(Fig. 2A). This suggests that the promoter region necessary for
GB-dependent transcriptional induction is between positions
	177 and 	86 or overlaps the 	86 site.
For pchP, a promoter truncation series fused to the gfp
reporter gene was constructed. The three longest constructs
retained GB-dependent induction of green fluorescent protein
fluorescence and did not show induction in the absence of
gbdR (Fig. 2B), while the shortest construct (D) showed no
induction by GB. This suggests that nucleotides within the
region between 	141 and 	75 bp are required for GB-depen-
dent transcriptional induction in the pchP promoter.
Evidence for GbdR binding to the plcH and pchP promoters.
Our studies above identified the regions of the plcH and
pchP promoters that were necessary for GbdR-dependent
induction of reporter activity in response to GB. To test the
hypothesis that GbdR interacts directly with the plcH pro-
moter, we used a 164-bp fragment of the plcH promoter
(corresponding to fragment C from the promoter deletion
analysis) in an EMSA. GbdR was purified as an MBP fusion
(MBP-GbdR); the MBP-GbdR expression construct was
sufficient to restore growth on GB in the gbdR mutant,
indicating that the fusion protein was functional. MBP-
GbdR specifically shifted the plcH promoter with increasing
concentrations of protein (Fig. 3A, lanes 2 and 3). This shift
could be competed with unlabeled plcH promoter (Fig. 3A,
lane 4). We also tested whether MBP-GbdR binds to the
pchP promoter by using a 260-bp fragment of the pchP
promoter (corresponding to fragment B of our promoter
deletion analysis). MBP-GbdR specifically shifted the pchP
promoter with increasing concentrations of protein, leading
to a larger proportion of the fragment shifting and to an
additional shifted band (Fig. 3B, lanes 2 to 4), although the
efficiency of binding was lower than that for plcH (Fig. 3A,
lane 8). This shift could be competed with unlabeled pchP
promoter (Fig. 3B, lane 5). The lower affinity of our MBP-
GbdR fusion for the pchP promoter under these conditions
is consistent with our promoter fusion data showing that the
induction of the pchP transcript is less than that seen with
the plcH promoter. The MBP-GbdR protein bound to both
the plcH and pchP promoters in the presence (Fig. 3A) and
absence (data not shown) of GB. Combined with the pro-
moter deletion analyses and the induction studies, this in
vitro binding is strong support for direct GbdR binding and
regulation at the plcH and pchP promoters.
Identification and mutation of conserved residues in the
plcH and pchP promoters that are necessary for GbdR induc-
tion. The promoter regions necessary for plcH and pchP in-
duction by GB were aligned with each other by use of LALIGN
FIG. 2. Promoter truncation analysis of the plcH and pchP promot-
ers. (A) Schematic map of the truncation constructs for the plcH
promoter, indicating their positions relative to the translational start
site, and their corresponding abilities to induce lacZ transcription in
medium with GB. The fusion constructs (A to D) were analyzed in the
WT and gbdR () strain backgrounds in the absence (	) and pres-
ence () of GB. (B) Schematic map of the truncation constructs for
the pchP promoter, indicating their positions relative to the transla-
tional start site, and corresponding gfp fluorescence driven by the
truncated pchP-reporter constructs, measured in arbitrary fluorescence
units after subtraction of the PAO1 WT (not expressing gfp) autofluo-
rescence baseline. Error bars represent standard deviations between
levels in three replicate cultures, and results were comparable between
at least three separate experiments.
FIG. 3. EMSA to examine interactions between MBP-GbdR and
plcH and pchP promoter fragments. (A) The WT plcH promoter frag-
ment was incubated alone or with MBP-GbdR (0.2 and 2 M) (lanes
1 to 3); to the reaction mix in lane 4, unlabeled plcH probe was added
in excess. Similar incubations were performed with a probe spanning
the same region but with two nucleotide substitutions (plcH**) (lanes
5 to 7). In lane 8, the shift of the pchP promoter probe is shown for
comparison. (B) The WT pchP promoter probe (lanes 1 to 5) and the
mutated promoter probe (pchP**) (lanes 6 to 8) were incubated with
MBP-GbdR at the concentrations shown (M). An excess of unla-
beled pchP probe was added to the reaction mix in lane 5.
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(11). One region of alignment corresponding to positions	174
to 	138 of the plcH promoter was also aligned via the
LALIGN pairwise method to the promoter regions of other genes
known to be controlled by GbdR, including gbcB, involved in
GB catabolism, and PA5396, the first gene in the putative
operon that contains the DMG catabolic genes. The alignment
of these promoters is shown in Fig. 4A. The transcriptional
start sites for the phosphate- and choline-dependent plcH tran-
scripts, as demonstrated by Vasil and coworkers (41), are
shown with dotted arrows (Fig. 4A).
To test the hypothesis that the aligned regions represented
the motif recognized by GbdR, we mutated GC residues
(marked with asterisks in Fig. 2) to adenines in both the plcH
and pchP promoters. In both cases, promoter fusion constructs
that were identical to plcH-C and pchP-C (Fig. 2A and B),
respectively, except for this 2-bp mutation, completely lacked
GbdR-dependent induction of transcription in medium with
GB (Fig. 4B). The 2-bp changes made in the plcH and pchP
promoters were not associated with either the 	10/	35 sites
or the ribosome binding site, consistent with the observation
that basal transcription of plcH or pchP in strains carrying the
mutated promoters is not different from that in strains carrying
the nonmutated versions (Fig. 4B). Mutation of the adjacent C
residue at 	169 to an adenine in the plcH promoter led to
abrogation of all GbdR-dependent induction, similar to the
mutations described above, while mutation of the G residue at
	161 led to a 59% decrease in induction of GbdR-dependent
transcription levels (data not shown).
To determine if the conserved promoter residues repre-
sented part of the region required for GbdR binding to the
promoters, we tested the ability of either the mutated plcH
(plcH**) or pchP (pchP**) promoter to bind MBP-GbdR in an
EMSA (Fig. 3A and B). The plcH** mutant promoter (Fig. 3A,
lanes 5 to 7) failed to show a shift at any tested concentration
of MBP-GbdR. The mutant pchP promoter (pchP**) could be
shifted by the addition of 3.0 M MBP-GbdR, but at a much
lower affinity than the WT promoter (Fig. 3B, lanes 6 to 8).
The defects of these mutant promoter fragments in associating
with MBP-GbdR suggest that these two base pairs are impor-
tant for GbdR binding.
GbdR controls plcH and pchP induction in response to
surfactant and BALF and in the mouse lung. The major
component of mammalian lung surfactant is PC. As such, this
compound represents a sizable pool of PlcH substrate within
the lung. To test whether GbdR controls plcH and pchP gene
induction in response to surfactant, we grew PAO1 WT and
gbdR strains in MOPS medium containing 10 mM pyruvate or
the same medium amended with the bovine-derived surfactant
Survanta. RNAs were harvested from cells, and qRT-PCR was
used to determine plcH, pchP, and rplU transcript levels; plcH
and pchP levels were normalized to levels of rplU. As shown in
Fig. 5A, P. aeruginosa WT induced plcH and pchP 6.4-fold and
8.3-fold, respectively, in the presence of Survanta over levels in
medium without surfactant addition. No induction was ob-
served in the gbdR mutant. Similar induction experiments
were performed with mouse BALF. P. aeruginosa strains were
resuspended in sterile filtered BALF or DPBS, with 10 mM
pyruvate added to both. In BALF-pyruvate, the normalized
transcript levels of plcH and pchP were 10.2- and 4.6-fold
higher, respectively, than levels in cells incubated in buffer with
pyruvate. No induction upon incubation in BALF was ob-
served for the gbdR strain (Fig. 5B).
To test the importance of GbdR for the regulation of plcH
and pchP in P. aeruginosa within the mouse lung, we infected
C57BL/6 mice with 1 
 108 CFU of either PAO1 or the gbdR
mutant via oropharyngeal aspiration (n  7 per group). After
24 h, the BALF was harvested and total RNA isolated and
analyzed by quantitative PCR. plcH and pchP transcript signals
were normalized to that of rplU. The results of the transcript
analyses are shown in Fig. 5C. Both plcH and pchP showed
significantly higher transcript levels in WT cells than in gbdR
cells. These data support an important role for GbdR in reg-
ulation of plcH and pchP in vivo.
Examination of the plcH positive feedback induction loop.
Based on the work presented here and data and interpretations
published by others (8, 41), we hypothesize that PlcH activity
initiates a series of catalytic steps leading to GbdR-dependent
induction of plcH and pchP, establishing a positive feedback
loop in which choline phosphate is degraded to GB, which
further induces plcH expression (Fig. 6A). To establish the role
of each predicted member of the proposed positive feedback
loop, we measured the expression of the plcH promoter
fusion in the PAO1 WT and in mutant strains, including the
plcHR, pchP::Tn, betB::Tn, and gbdR strains, in the pres-
ence of MOPS-Survanta medium (containing approximately
0.25 mg/ml PC) (Fig. 6B). As shown above (Fig. 5A), plcH and
pchP transcription in this medium was induced in the WT but
not in the gbdR mutant. There was no induction of the plcH
FIG. 4. Role of two conserved base pairs in the plcH and pchP
promoters in GbdR-dependent induction. (A) Schematic of the plcH
promoter showing the conserved promoter region, with base pairs
denoting the distance from the translational start site. The phosphate-
and choline-dependent transcriptional start sites are shown with dot-
ted arrows (41). The alignment shows a common promoter region
present near four genes controlled by GbdR. The asterisks mark the
two base pairs changed to adenines in the mutant constructs. (B) The
nonmutated promoter fusions were analyzed in the WT and gbdR ()
strain backgrounds in the presence () and absence (	) of GB. The
mutated constructs with the 2-bp alteration were analyzed in the WT
background (WT**). Error bars represent standard deviations be-
tween levels in three replicate cultures, and results were comparable
between at least three separate experiments.
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transcriptional fusion in the plcH, pchP, or betB mutant, sug-
gesting that PC catabolism was necessary for induction of plcH
by GbdR (Fig. 6B). To explore the role of choline phosphate
(ChoP), choline, and GB in the pathway, we added 0.25 mM of
each compound to the medium and assessed plcH transcription
activity. The addition of ChoP resulted in plcH induction in a
plcHR strain but not in the pchP::Tn or betB::Tn strain, un-
derlining the importance of the PchP phosphatase in ChoP
hydrolysis and resultant choline catabolite-dependent gene in-
duction. The addition of choline restored the induction of plcH
in the plcHR and pchP::Tn strains, but choline was unable to
induce the plcH promoter fusion in the betB::Tn strain, as
reported previously (31). GB restored plcH induction in all
strains but the gbdR mutant. These data highlight the steps
critical for plcH induction in lung surfactant as well as establish
the role of each enzyme in the initiation of the plcH positive
feedback induction system.
DISCUSSION
In this study, we identified GbdR as the transcription factor
required for induction of the plcH and pchP transcripts in the
presence of GB and DMG. Using promoter deletion and mu-
tation analysis, we identified residues required for GbdR-de-
pendent induction and demonstrated direct binding to the
plcH and pchP promoters by EMSA. GbdR is required for
FIG. 5. GbdR-dependent regulation of plcH and pchP transcripts
in Survanta and murine BALF and during mouse lung infection.
(A) RNAs from WT (black bars) and gbdR (white bars) cells grown
in medium with and without surfactant were analyzed by qRT-PCR to
determine relative plcH and pchP transcript levels; transcript levels
were normalized to those of the rplU control transcript. The levels of
induction represent transcript levels in cells grown in medium with
Survanta divided by levels in cells grown with pyruvate as the sole
source of carbon. (B) qRT-PCR with cells grown in filter-sterilized
murine BALF from uninfected mice. Induction is reported as in panel
A. (C) qRT-PCR was conducted on RNAs isolated from BALF of
mice infected with either PAO1 WT or PAO1 gbdR for 24 h. Tran-
script levels are reported as plcH or pchP transcript levels relative to
levels of the rplU transcript. There were seven mice infected for each
group, and standard errors are shown.
FIG. 6. PlcH is the initiator of a positive feedback loop during P.
aeruginosa exposure to lung surfactant (Survanta). (A) Model for the
GbdR-dependent, GB-induced PlcH positive feedback loop. Thick
solid arrows represent catalytic activity conducted by the adjacent
protein, and thin solid arrows represent transport events. Dashed ar-
rows represent induction events. (B) PAO1 WT and mutants defective
in plcH, pchP, betB, and gbdR carrying the pMW22 plcH reporter
construct were exposed to MOPS medium with diluted Survanta (1%).
Similar cultures were amended with phosphorylcholine (ChoP), cho-
line, or GB to a final concentration of 0.25 mM. Induction is reported
as the Miller units for the listed induction conditions divided by the
Miller units for comparable cultures grown in MOPS-pyruvate me-
dium. Error bars represent standard deviations between levels in three
replicate cultures, and results are comparable between at least three
separate experiments.
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induction of plcH and pchP in bovine lung surfactant and
mouse BALF. In addition, using an acute model of mouse lung
infection, we showed that GbdR plays an important role in
induction of plcH and pchP in vivo.
The two known stimuli of plcH regulation, low phosphate
and the presence of GB, regulate plcH in different ways. Tran-
scriptional induction of the plcH gene in response to limiting
phosphate conditions is controlled by PhoB and is hypothe-
sized to function as part of a phosphate-scavenging system
(36). The acquisition of phosphate from PC and SM will even-
tually turn off plcH induction via the Pho system. The regula-
tion of plcH transcription by GbdR in response to GB repre-
sents a positive feedback regulatory scheme. As PlcH activity
releases more choline from PC and SM, conversion of choline
to GB will lead to induction of plcH transcription by GbdR. By
adding each metabolite in the proposed plcH induction path-
way (Fig. 6A) to strains capable or incapable of each predicted
catabolic step, we were able to fully validate the role of each
intermediate in the PlcH-initiated positive feedback loop dur-
ing P. aeruginosa interaction with host-derived phospholipids
(Fig. 6B). The positive feedback regulation, leading to in-
creased PlcH production and increased host damage, may in
part explain the striking phenotypes of plcH mutants in a va-
riety of animal model systems (12, 27, 29, 46).
While P. aeruginosa produces multiple PLCs and phosphata-
ses, PlcH and PchP appear to be of major importance for
inducing GbdR induction of virulence-regulated genes (2, 26).
In PC-rich Survanta, experiments using the plcH reporter sys-
tem supported the hypothesis that PlcH is critical for ChoP
acquisition (Fig. 6B), suggesting that other described PLCs (2,
26) do not play a significant role in PC hydrolysis under these
conditions. The phosphorylcholine phosphatase (PchP) was
identified biochemically and subsequently cloned (18, 20). We
are unaware of any published reports that verify the require-
ment of PchP for hydrolysis of ChoP in an environment similar
to that used in our assay. Although a number of other putative
phosphatases are produced by P. aeruginosa, some of which are
highly induced during growth on Survanta (M. J. Wargo and
D. A. Hogan, unpublished data), we established that, in the
time frame of our assay, PchP is required for plcH induction in
Survanta (Fig. 6B).
plcH transcript accumulation is likely impacted by many
different factors. Because there are several catabolic steps in-
volved in generating GB for induction of plcH by GbdR in PC-
and SM-rich environments such as the lung, induction of plcH
by GB and DMG could be regulated at a number of points. In
particular, while we have discussed PlcH as a single enzyme for
the sake of simplicity, PlcH can be present freely or in complex
with PlcR1 or PlcR2, two chaperones encoded by overlapping
reading frames of the plcR gene (6). These complexes have
different biochemical activities from that of the free enzyme
(17). Interestingly, it has been shown that choline induction
fails to robustly induce the plcR transcript, while phosphate
starvation is capable of inducing both plcH and plcR (17). plcH
transcript stability can also vary in response to iron levels (25).
The availability of the choline-derived GB-inducing signal
could also be affected by choline phosphatase activity, choline
uptake, or choline conversion of choline into GB. betAB gene
induction by choline is independent of GbdR (30, 42, 43).
Previous work has shown only very slight alterations (2-fold
changes) in gbdR transcript levels upon growth in media con-
taining choline, GB, or DMG (45); mechanisms for regulating
GbdR activity have not been explored. Due to the complexity
of the plcH positive feedback loop, there are a variety of
opportunities for the development of strategies for the inhibi-
tion of this pathway in vivo.
Although these analyses elucidate the major GB- and DMG-
dependent regulator of plcH and pchP and show the role of
GbdR during lung infection, several questions remain to be
answered. First, it is important to understand how the phos-
phate and GB/DMG signals are integrated at both the plcH
and pchP promoters by assessing the interaction between
GbdR and PhoB. Second, understanding the mechanism of
catabolite repression (34) of these loci and other genes related
to GB and DMG catabolism will enable us to better under-
stand the regulation of virulence factors by cellular metabolic
processes. Finally, understanding the intricacies of GbdR-de-
pendent regulation in P. aeruginosa during infection could shed
light on the respective roles of GB utilization as a carbon and
nitrogen source, an osmoprotectant (38, 44), and an inducer of
virulence-related genes such as plcH in different environments.
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